Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Accrued Liabilities

Note 7 - Accrued Liabilities

6 Months Ended

Jun. 30, 2024

Notes to Financial Statements

Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]

7. Accrued Liabilities

Accrued liabilities as of June 30, 2024 and December 31, 2023 consisted of the following:

	*June 30, 2024*		*December 31, 2023*
Salaries, benefits and related expenses	$	1,459	$	2,058
Device warranty		417		461
Other		97		145
Total	$	1,973	$	2,664

Warranty

The current portion of the device warranty liability is classified as a component of Accrued liabilities, while the long-term portion of the device warranty liability is classified as a component of Other non-current liabilities in the condensed consolidated balance sheets. A reconciliation of the changes in the device warranty liability for the three and six months ended June 30, 2024 is as follows:

	*Three Months Ended*			*Six Months Ended*
	*June 30, 2024*			*June 30, 2024*
Balance at beginning of the period	$	526		$	566
Additions for estimated future expense		195			316
Incurred costs		(160	)		(321	)
Balance at end of the period	$	561		$	561

	*Balance as of June 30, 2024*
Current portion	$	417
Long-term portion		144
Total	$	561